Why the study?
Youth with obesity have increased cardiometabolic risk, but identifying those at highest risk remains difficult, and the clinical utility of NMR-derived biomarkers in youth is unclear.
Do NMR-derived biomarkers (LPIR, GlycA, BCAA, and glycine) correlate with insulin resistance and glycemia in youth across the spectrum of glucose tolerance?
Do NMR-derived biomarkers (LPIR, GlycA, BCAA, and glycine) correlate with insulin resistance and glycemia in youth across the spectrum of glucose tolerance?
Plasma NMR-derived markers, particularly LPIR, are strongly associated with insulin resistance and glycemia in youth and may serve as non-insulin dependent predictive tools for cardiometabolic risk.
Answers are grounded in this paper and cite their sources.
Supports NMR biomarker exploration for youth insulin resistance assessment; leaves open clinical utility pending longitudinal validation.
Youth with obesity have an increased risk for cardiometabolic disease, but identifying those at highest risk remains a challenge. Four biomarkers that might serve this purpose are “by products” of clinical NMR LipoProfile® lipid testing: LPIR (Lipoprotein Insulin Resistance Index), GlycA (inflammation marker), BCAA (total branched-chain amino acids), and glycine. All are strongly related to insulin resistance and type 2 diabetes (T2DM) in adults (glycine inversely) and are independent of biological and methodological variations in insulin assays. However, their clinical utility in youth is unclear. We compared fasting levels of these biomarkers in 186 youth (42 lean normal glucose tolerant (NGT), 88 obese NGT, 23 with prediabetes (PreDM), and 33 with T2DM. All four biomarkers were associated with obesity and glycemia in youth. LPIR and GlycA were highest in youth with PreDM and T2DM, whereas glycine was lowest in youth with T2DM. While all four were correlated with HOMA-IR (Homeostatic Model Assessment for Insulin Resistance), LPIR had the strongest correlation (LPIR: r = 0.6; GlycA: r = 0.4, glycine: r = −0.4, BCAA: r = 0.2, all P < 0.01). All four markers correlated with HbA1c (LPIR, GlycA, BCAA: r ≥ 0.3 and glycine: r = −0.3, all P < 0.001). In multi-variable regression models, LPIR, GlycA, and glycine were independently associated with HOMA-IR (Adjusted R2 = 0.473, P < 0.001) and LPIR, glycine, and BCAA were independently associated with HbA1c (Adjusted R2 = 0.33, P < 0.001). An LPIR index of >44 was associated with elevated blood pressure, BMI, and dyslipidemia. Plasma NMR-derived markers were related to adverse markers of cardiometabolic risk in youth. LPIR, either alone or in combination with GlycA, should be explored as a non-insulin dependent predictive tool for development of insulin resistance and diabetes in youth. Clinical Trial Registration Clinicaltrials.gov , identifier NCT:02960659
No takes yet. Share an insight, caveat, or question.
Chung et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: